Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorCorti, Francesca
dc.contributor.authorInfante, Gabriele
dc.contributor.authorElez Fernandez, Mª Elena
dc.contributor.authorRos Montañá, Fco. Javier
dc.contributor.authorFakih, Marwan
dc.contributor.authorPietrantonio, Filippo
dc.contributor.authorLonardi, Sara
dc.date.accessioned2022-04-22T13:01:39Z
dc.date.available2022-04-22T13:01:39Z
dc.date.issued2021-08
dc.identifier.citationPietrantonio F, Lonardi S, Corti F, Infante G, Elez ME, Fakih M, et al. Nomogram to predict the outcomes of patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors. J Immunother Cancer. 2021 Aug;9(8):e003370.
dc.identifier.issn2051-1426
dc.identifier.urihttps://hdl.handle.net/11351/7373
dc.descriptionNeoplàsies gastrointestinals; Immunoteràpia
dc.description.sponsorshipThe authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
dc.language.isoeng
dc.publisherBMJ
dc.relation.ispartofseriesJournal for ImmunoTherapy of Cancer;9(8)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectRecte - Càncer - Tractament
dc.subjectCòlon - Càncer - Tractament
dc.subjectNomografia (Matemàtica)
dc.subject.meshColorectal Neoplasms
dc.subject.mesh/drug therapy
dc.subject.meshNomograms
dc.subject.meshMicrosatellite Instability
dc.titleNomogram to predict the outcomes of patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1136/jitc-2021-003370
dc.subject.decsneoplasias colorrectales
dc.subject.decs/farmacoterapia
dc.subject.decsnomogramas
dc.subject.decsinestabilidad de microsatélites
dc.relation.publishversionhttp://dx.doi.org/10.1136/jitc-2021-003370
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Pietrantonio F, Corti F] Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. [Lonardi S] Medical Oncology 3, Istituto Oncologico Veneto IOV-IRCSS, Padua, Italy. [Infante G] Unit of Clinical Epidemiology and Trial Organization, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. [Elez ME, Ros J] Servei d’Oncologia Mèdica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Fakih M] Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, California, USA
dc.identifier.pmid34429334
dc.identifier.wos000688528100002
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Thumbnail

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple